KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $3.1 million.

  • Opko Health's Capital Expenditures fell 6050.14% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 3357.35%. This contributed to the annual value of $25.0 million for FY2024, which is 5367.13% up from last year.
  • Opko Health's Capital Expenditures amounted to $3.1 million in Q3 2025, which was down 6050.14% from $3.3 million recorded in Q2 2025.
  • Opko Health's Capital Expenditures' 5-year high stood at $9.2 million during Q1 2021, with a 5-year trough of $3.0 million in Q4 2023.
  • For the 5-year period, Opko Health's Capital Expenditures averaged around $5.7 million, with its median value being $5.4 million (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 8884.13% in 2024, then tumbled by 6050.14% in 2025.
  • Quarter analysis of 5 years shows Opko Health's Capital Expenditures stood at $6.7 million in 2021, then dropped by 5.85% to $6.3 million in 2022, then plummeted by 52.3% to $3.0 million in 2023, then surged by 79.12% to $5.4 million in 2024, then plummeted by 42.08% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.3 million for Q2 2025, and $3.2 million during Q1 2025.